Demonstration Formulary
Home
About
Admin
netFormulary
Chapters
Medicines A-Z
News
Mobile
Reports
Feedback
Search
Results
Looking for
Fingolimod
found
4 matches
Links
Link to Drug Section
Link to document
MHRA: Fingolimod - not recommended for patients at known risk of cardiovascular adverse events. New advice for extended early monitoring (08.02.04)
MHRA: Fingolimod (Gilenya®): not recommended for patients at known risk of cardiovascular adverse events (08.02.04)
NICE TA254: Fingolimod for highly active relapsing remitting multiple sclerosis (08.02.04)
NICE TA254: Fingolimod for the treatment of highly active relapsing–remitting multiple sclerosis (08.02.04)
